Nurix Therapeutics
NRIX
$16.59
Share price
7.73%
Change (1 day)
65.73%
Change (1 year)
Categories
Nurix Therapeutics (NRIX) - P/B ratio
P/B ratio as of May 2024 : 5.57
According to Nurix Therapeutics's latest financial reports the company has a price-to-book ratio of 5.57.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nurix Therapeutics - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.50 | 46.46% |
| 2022-12-31 | 1.70 | -54.82% |
| 2021-12-31 | 3.77 | -14.27% |
| 2020-12-31 | 4.40 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -51.30% | 🇺🇸 USA |